Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For AMKR
Valuation Weak
14%
Profitability n.A.
Fin. Growth Weak
17%
Leverage & Liquidity Weak
33%
Per Share Metrics Bad
0%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 1.22 2.34 2.31
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -8.51 0.76 0.83
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 0.79 16.25 16.12
Cash -1.46 6.39 6.49
Capex 59.60 -0.39 -0.97
Free Cash Flow -80.33 0.27 1.37
Revenue -22.12 5.55 7.13
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -7.32 0.15 0.16
Operating Margin -40.87 0.05 0.09
ROA -49.26 < 0.005 0.02
ROE -50.34 0.01 0.03
ROIC -50.99 0.01 0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of AMKR is permitted for members.
5 Growth
The "Growth Entry" for the Focus of AMKR is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of AMKR is permitted for members.